The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glycated Hemoglobin Testing-Global Market Insights and Sales Trends 2024
Synopsis
Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo lysis at the same time, HbA1C is taken as a limited measure of three months. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.
The global Glycated Hemoglobin Testing market size is expected to reach US$ 497.4 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Glycated Hemoglobin Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Diagnostic Laboratories and Academic and Research Institutes, are propelling Glycated Hemoglobin Testing market. Lab Based Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-Care Test segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycated Hemoglobin Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycated Hemoglobin Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycated Hemoglobin Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycated Hemoglobin Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycated Hemoglobin Testing covered in this report include Abbott, Bio-Rad Laboratories, Danaher, EKF Diagnostics and F. Hoffmann-La Roche, etc.
The global Glycated Hemoglobin Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Bio-Rad Laboratories
Danaher
EKF Diagnostics
F. Hoffmann-La Roche
Global Glycated Hemoglobin Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycated Hemoglobin Testing market, Segment by Type:
Lab Based Test
Point-of-Care Test
Global Glycated Hemoglobin Testing market, by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glycated Hemoglobin Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo lysis at the same time, HbA1C is taken as a limited measure of three months. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.
The global Glycated Hemoglobin Testing market size is expected to reach US$ 497.4 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Glycated Hemoglobin Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Diagnostic Laboratories and Academic and Research Institutes, are propelling Glycated Hemoglobin Testing market. Lab Based Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-Care Test segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycated Hemoglobin Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycated Hemoglobin Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycated Hemoglobin Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycated Hemoglobin Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycated Hemoglobin Testing covered in this report include Abbott, Bio-Rad Laboratories, Danaher, EKF Diagnostics and F. Hoffmann-La Roche, etc.
The global Glycated Hemoglobin Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Bio-Rad Laboratories
Danaher
EKF Diagnostics
F. Hoffmann-La Roche
Global Glycated Hemoglobin Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycated Hemoglobin Testing market, Segment by Type:
Lab Based Test
Point-of-Care Test
Global Glycated Hemoglobin Testing market, by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glycated Hemoglobin Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Glycated Hemoglobin Testing
1.1 Glycated Hemoglobin Testing Market Overview
1.1.1 Glycated Hemoglobin Testing Product Scope
1.1.2 Glycated Hemoglobin Testing Market Status and Outlook
1.2 Global Glycated Hemoglobin Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Glycated Hemoglobin Testing Market Size by Region (2018-2029)
1.4 Global Glycated Hemoglobin Testing Historic Market Size by Region (2018-2023)
1.5 Global Glycated Hemoglobin Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Glycated Hemoglobin Testing Market Size (2018-2029)
1.6.1 North America Glycated Hemoglobin Testing Market Size (2018-2029)
1.6.2 Europe Glycated Hemoglobin Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Glycated Hemoglobin Testing Market Size (2018-2029)
1.6.4 Latin America Glycated Hemoglobin Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Glycated Hemoglobin Testing Market Size (2018-2029)
2 Glycated Hemoglobin Testing Market by Type
2.1 Introduction
2.1.1 Lab Based Test
2.1.2 Point-of-Care Test
2.2 Global Glycated Hemoglobin Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Glycated Hemoglobin Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Glycated Hemoglobin Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Glycated Hemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Glycated Hemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Glycated Hemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Glycated Hemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Glycated Hemoglobin Testing Revenue Breakdown by Type (2018-2029)
3 Glycated Hemoglobin Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Diagnostic Laboratories
3.1.4 Academic and Research Institutes
3.2 Global Glycated Hemoglobin Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Glycated Hemoglobin Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Glycated Hemoglobin Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Glycated Hemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Glycated Hemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Glycated Hemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Glycated Hemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Glycated Hemoglobin Testing Revenue Breakdown by Application (2018-2029)
4 Glycated Hemoglobin Testing Competition Analysis by Players
4.1 Global Glycated Hemoglobin Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glycated Hemoglobin Testing as of 2022)
4.3 Date of Key Players Enter into Glycated Hemoglobin Testing Market
4.4 Global Top Players Glycated Hemoglobin Testing Headquarters and Area Served
4.5 Key Players Glycated Hemoglobin Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Glycated Hemoglobin Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Glycated Hemoglobin Testing Products, Services and Solutions
5.1.4 Abbott Glycated Hemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Bio-Rad Laboratories
5.2.1 Bio-Rad Laboratories Profile
5.2.2 Bio-Rad Laboratories Main Business
5.2.3 Bio-Rad Laboratories Glycated Hemoglobin Testing Products, Services and Solutions
5.2.4 Bio-Rad Laboratories Glycated Hemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Glycated Hemoglobin Testing Products, Services and Solutions
5.3.4 Danaher Glycated Hemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.3.5 EKF Diagnostics Recent Developments
5.4 EKF Diagnostics
5.4.1 EKF Diagnostics Profile
5.4.2 EKF Diagnostics Main Business
5.4.3 EKF Diagnostics Glycated Hemoglobin Testing Products, Services and Solutions
5.4.4 EKF Diagnostics Glycated Hemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.4.5 EKF Diagnostics Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Glycated Hemoglobin Testing Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Glycated Hemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
6 North America
6.1 North America Glycated Hemoglobin Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Glycated Hemoglobin Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Glycated Hemoglobin Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Glycated Hemoglobin Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Glycated Hemoglobin Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Glycated Hemoglobin Testing Market Dynamics
11.1 Glycated Hemoglobin Testing Industry Trends
11.2 Glycated Hemoglobin Testing Market Drivers
11.3 Glycated Hemoglobin Testing Market Challenges
11.4 Glycated Hemoglobin Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
